{"id":"https://openalex.org/W2590790266","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2032","title":"Phase I study of vorinostat in combination with temozolomide in patients with malignant gliomas.","display_name":"Phase I study of vorinostat in combination with temozolomide in patients with malignant gliomas.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590790266","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2032","mag":"2590790266"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.2032","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2032","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.2032","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021656597","display_name":"Patrick Yung Wen","orcid":"https://orcid.org/0000-0002-0774-7700","observed_orcids":["https://orcid.org/0000-0002-0774-7700","https://orcid.org/0000-0003-3224-3042","https://orcid.org/0000-0002-2452-0540"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Y. Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037535298","display_name":"Vinay K. Puduvalli","orcid":"https://orcid.org/0000-0001-8396-9500","observed_orcids":["https://orcid.org/0000-0001-8396-9500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. K. Puduvalli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075492015","display_name":"John G. Kuhn","orcid":"https://orcid.org/0000-0002-7359-8643","observed_orcids":["https://orcid.org/0000-0002-7359-8643"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. G. Kuhn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069133252","display_name":"Jennifer Meyer Reid","orcid":"https://orcid.org/0000-0003-4638-054X","observed_orcids":["https://orcid.org/0000-0003-4638-054X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. Reid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061018141","display_name":"Kathleen R. Lamborn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Lamborn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063511816","display_name":"Timothy Francis Cloughesy","orcid":"https://orcid.org/0000-0002-8656-7483","observed_orcids":["https://orcid.org/0000-0002-8656-7483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. F. Cloughesy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112605224","display_name":"Shannon Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. M. Chang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091053515","display_name":"Jan Drappatz","orcid":"https://orcid.org/0000-0001-8187-7119","observed_orcids":["https://orcid.org/0000-0001-8187-7119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Drappatz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006268625","display_name":"W.K. Alfred Yung","orcid":"https://orcid.org/0000-0002-1669-0793","observed_orcids":["https://orcid.org/0000-0002-1669-0793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. K. A. Yung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109054807","display_name":"MARCEL R. GILBERT","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. R. Gilbert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050941870","display_name":"H. Ian Robins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. I. Robins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014264452","display_name":"Frank Scott Lieberman","orcid":"https://orcid.org/0000-0003-2577-3336","observed_orcids":["https://orcid.org/0000-0003-2577-3336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. S. Lieberman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. B. Lassman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110580704","display_name":"Renee M. McGovern","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. M. McGovern","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091849918","display_name":"Serena Desideri","orcid":"https://orcid.org/0009-0007-0682-6080","observed_orcids":["https://orcid.org/0009-0007-0682-6080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Desideri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040906733","display_name":"X. Ye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X. Ye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. M. Ames","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014445762","display_name":"Igor Espinoza\u2010Delgado","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. J. Espinoza-Delgado","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010420312","display_name":"Stuart A. Grossman","orcid":"https://orcid.org/0000-0002-3726-7679","observed_orcids":["https://orcid.org/0000-0002-3726-7679"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. A. Grossman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108230097","display_name":"Michael Prados","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Prados","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"2032","last_page":"2032"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":1.0},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/high-grade-glioma","display_name":"high-grade glioma","score":0.8080000281333923},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anaplastic-glioma","display_name":"anaplastic glioma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7979999780654907},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8130000233650208},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.6240000128746033},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.38499999046325684},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.3160000145435333},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.31700000166893005},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.9057535529136658},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.894196629524231},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.8089488744735718},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6284069418907166},{"id":"https://openalex.org/C2779083369","wikidata":"https://www.wikidata.org/wiki/Q486092","display_name":"Anaplastic astrocytoma","level":4,"score":0.5602822303771973},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5588565468788147},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.48388800024986267},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4760596454143524},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43965595960617065},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4275937080383301},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.40300941467285156},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3210948407649994},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.20555070042610168},{"id":"https://openalex.org/C2778880634","wikidata":"https://www.wikidata.org/wiki/Q177755","display_name":"Astrocytoma","level":3,"score":0.16745945811271667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.15427231788635254},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.2032","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2032","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.2032","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2609068367","https://openalex.org/W2268389957","https://openalex.org/W2108985372","https://openalex.org/W2600771186","https://openalex.org/W2602283374","https://openalex.org/W2783692774","https://openalex.org/W2580232946","https://openalex.org/W2781261700","https://openalex.org/W2111013340","https://openalex.org/W2900241443"],"abstract_inverted_index":{"2032":[0],"Background:":[1],"Vorinostat":[2,256,361],"(V)":[3],"is":[4,205,362],"an":[5,300,382],"oral":[6],"histone":[7],"deacetylase":[8],"inhibitor.":[9],"In":[10],"preclinical":[11],"studies":[12],"it":[13],"inhibits":[14],"growth":[15],"of":[16,43,93,146,203,235,293,303,317,332,389],"glioblastoma":[17],"(GBM)":[18],"lines":[19],"and":[20,61,69,86,113,134,275,309,344,358,372,384,393],"has":[21],"additive":[22],"activity":[23],"when":[24],"combined":[25],"with":[26,47,51,216,311,321,336,367,391],"temozolomide":[27],"(TMZ)":[28],"or":[29,81,109],"radiotherapy":[30],"(RT).":[31],"Methods:":[32],"The":[33,148,201,271,315,330,352],"Adult":[34],"Brain":[35],"Tumor":[36],"Consortium":[37],"conducted":[38],"a":[39],"phase":[40,386],"I":[41],"study":[42],"V":[44,102,294,304,318,333],"in":[45,49,143,162,214,229,341,365,395],"combination":[46,215,366],"TMZ":[48,94,217,237,312,322,337,394],"patients":[50,171,182,231],"malignant":[52],"gliomas":[53,63],"(MG).":[54],"Eligibility":[55],"criteria":[56],"were":[57,121,227,279,356],"histologically":[58],"proven":[59],"GBM":[60,397],"anaplastic":[62],"(AG)":[64],"who":[65],"had":[66,70],"received":[67,90],"RT":[68,392],"not":[71],"progressed":[72],"on":[73,95,106,110,208,297,306],"TMZ,":[74],">":[75],"18":[76],"yrs":[77,195],"old,":[78],"KPS":[79,198],"60":[80],"greater,":[82],"adequate":[83],"marrow":[84],"reserve":[85],"organ":[87],"function.":[88],"Patients":[89],"150-200":[91],"mg/m2":[92],"days":[96,307],"(d)":[97],"1-5":[98],"every":[99,115,211,222,327],"28":[100,116,212,223,328],"d.":[101,117,224,329],"was":[103,141,153,172,295,313,319,334],"administered":[104,305],"either":[105],"d":[107,111,209,213,221,326,350],"1-14,":[108],"1-7":[112,308],"15-22,":[114],"Dose-limiting":[118],"toxicities":[119],"(DLT),":[120],"defined":[122,154],"as":[123,155],"any":[124,135],"grade":[125,131,136],"4":[126,190],"hematologic":[127],"toxicity":[128,373],"except":[129],"for":[130,219,273,286,324,339,347],"3":[132,137],"thrombocytopenia,":[133],"non-hematologic":[138],"toxicities.":[139],"Escalation":[140],"performed":[142],"standard":[144],"groups":[145],"3.":[147],"maximum":[149],"tolerated":[150,364],"dose":[151,157,234,260],"(MTD)":[152],"the":[156,175,287,291],"at":[158],"which":[159],"DLTs":[160,226,355],"occurred":[161],"no":[163],"more":[164],"than":[165],"1/6":[166],"patients.":[167],"An":[168],"additional":[169],"10":[170],"added":[173],"to":[174,381],"MTD":[176,202,316,331],"dose.":[177],"Results:":[178],"To":[179],"date,":[180],"59":[181],"have":[183],"been":[184],"enrolled":[185],"(39":[186],"GBM;":[187],"16":[188,230],"AG;":[189],"others).":[191],"Median":[192],"age":[193],"51":[194],"(25-81);":[196],"median":[197],"90":[199],"(60-100).":[200],"vorinostat":[204,274,390],"300":[206],"mg/d":[207],"1-14":[210],"150mg/m2":[218,323,338],"5":[220,325],"No":[225],"seen":[228],"receiving":[232],"this":[233,298],"V.":[236],"pharmacokinetic":[238],"data":[239,374],"(PKs):":[240],"(n=16)":[241,258],"Cmax":[242,262],"5.2":[243],"(+/-":[244],"1.55)":[245],"mcg/ml;":[246],"AUC":[247],"20.1":[248],"(+/-4.66)":[249],"mcg":[250],"x":[251,269],"hr/ml;":[252],"t1/2":[253,272],"2.0":[254],"(+/-0.32)/hr].":[255],"PKs":[257],"(300mg":[259],"level):":[261],"267":[263],"(+/-174)ng/ml;":[264],"AUC0-8":[265],"603":[266],"(+/-197)":[267],"ng":[268],"hr/ml].":[270],"its":[276],"glucuronide":[277],"metabolite":[278],"identical":[280],"(1.6":[281],"hrs)":[282],"vs.":[283],"5.6":[284],"hrs":[285],"acid":[288],"metabolite.":[289],"Because":[290],"exposure":[292],"low":[296],"schedule,":[299],"alternative":[301],"schedule":[302],"15-22":[310],"examined.":[314],"500mg/d":[320],"400mg/d":[335],"5d":[340],"cycle":[342],"1":[343],"200mg":[345],"m2/d":[346],"subsequent":[348],"5/28":[349],"cycles.":[351],"most":[353],"common":[354],"fatigue":[357],"thrombocytopenia.":[359],"Conclusions:":[360],"well":[363],"TMZ.":[368],"Updated":[369],"PK,":[370],"efficacy":[371],"will":[375],"be":[376],"presented.":[377],"These":[378],"results":[379],"led":[380],"ABTC":[383],"NCCTG":[385],"II":[387],"trial":[388],"newly-diagnosed":[396]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-03T00:00:00"}